Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Assets:
Cash and due from banks	$ 722,906	$ 617,569
Interest-bearing deposits	9,495,777	7,985,057
Federal funds sold	5,925	0
Resell agreements	9,650	84,650
Total cash and cash equivalents	10,234,258	8,687,276
Securities held to maturity, net of allowance for credit losses of $310 at both 2024 and 2023	3,533,775	3,619,428
Securities available for sale, at estimated fair value	15,043,625	16,578,371
Trading account securities	33,910	31,717
Loans, net of unearned discounts	20,754,813	18,824,251
Less: Allowance for credit losses on loans	(270,151)	(245,996)
Net loans	20,484,662	18,578,255
Premises and equipment, net	1,245,377	1,190,033
Accrued interest receivable and other assets	1,944,652	2,159,958
Total assets	52,520,259	50,845,038
Liabilities:
Non-interest-bearing demand deposits	14,441,820	14,926,094
Interest-bearing deposit	28,280,928	26,994,474
Total deposits	42,722,748	41,920,568
Federal funds purchased	21,975	14,200
Repurchase agreements	4,342,941	4,127,188
Junior subordinated deferrable interest debentures, net of unamortized issuance costs	123,184	123,127
Subordinated notes, net of unamortized issuance costs	99,648	99,491
Accrued interest payable and other liabilities	1,311,175	844,017
Total liabilities	48,621,671	47,128,591
Shareholders’ Equity:
Preferred stock, par value $0.01 per share; 10,000,000 shares authorized; 150,000 Series B shares ($1,000 liquidation preference) issued in 2024 and 2023	145,452	145,452
Common stock, par value $0.01 per share; 210,000,000 shares authorized; 64,404,582 shares issued in both 2024 and 2023	644	644
Additional paid-in capital	1,075,572	1,055,809
Retained earnings	3,951,482	3,657,688
Accumulated other comprehensive income (loss), net of tax	(1,252,004)	(1,119,219)
Treasury stock, at cost; 207,150 shares in 2024 and 219,295 in 2023	(22,558)	(23,927)
Total shareholders’ equity	3,898,588	3,716,447
Total liabilities and shareholders’ equity	$ 52,520,259	$ 50,845,038